Skip to content
Clinical Trials – home

Spitalul Clinic Dr. C.I. Parhon Iasi

Research site

Romania Bulevardul Carol I Nr. 50, 700503 Iasi, Romania

  • 1 trial recruiting
  • Arteriosclerosis · Lupus nephritis · Systemic lupus erythematosus
  • Adult patients

About Specializations

Spitalul Clinic Dr. C.I. Parhon Iasi in Iasi, Romania specialises in clinical trials of conditions such as Arteriosclerosis, Lupus nephritis, Systemic lupus erythematosus, Urinary tract infection, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research in End-Stage Kidney Disease

The medical center is at the forefront of cardiovascular research specifically targeting patients with end-stage kidney disease (ESKD). This research is pivotal in understanding and mitigating the cardiovascular complications that frequently accompany ESKD.

  • Reduction of hs-CRP in ESKD patients
  • Innovative therapeutic approaches for atherosclerotic cardiovascular disease
  • Integration of dialysis and cardiovascular care

Through the study of CSL300 (Clazakizumab), the center is exploring novel intravenous treatments aimed at reducing inflammation markers such as high-sensitivity C-reactive protein (hs-CRP), which are crucial in managing cardiovascular risks in dialysis patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bulevardul Carol I Nr. 50700503 IasiRomania
Recruiting now
1 trial
Conditions studied
4

More sites in IasiRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Systemic lupus erythematosus+1

Not yet recruiting

Randomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.